Table 3.
Parameter | Cases (n = 136) | Controls (n = 183) | p a (vs controls) |
---|---|---|---|
GPx1 activity [U/g Hb] | 22.3 ± 5.5 (11.1–35.0) | 20.5 ± 4.7 (10.7–29.7) | 0.0036 |
GPx3 activity [U/mL] | 0.189 ± 0.037 (0.108–0.308) | 0.191 ± 0.032 (0.125–0.297) | 0.7491 |
SOD1 activity [U/mg Hb] | 6.84 ± 1.24 (4.48–11.53) | 6.90 ± 1.52 (3.03–10.91) | 0.8590 |
Cp activity [g/L] | 0.58 ± 0.18 (0.13–1.05) | 0.66 ± 0.21 (0.31–1.75) | 0.0005 |
TBARS concentration [μmol/L] | 2.62 ± 0.96 (1.01–5.27) | 2.24 ± 0.83 (1.00–5.90) | 0.0003 |
Se concentration [μg/L] | 55.2 ± 14.7 (23.2–99.9) | 57.0 ± 11.8 (29.1–97.7) | 0.1791 |
Data expressed as mean ± standard deviation and (range). Significant p values are presented in bold
athe Mann–Whitney test